Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh

G. Balakrish Nair, Firdausi Qadri, Jan Holmgren, Ann-Mari Svennerholm, Ashrafus Safa, Nurul A. Bhuiyan, Q. Shafi Ahmad, Shah M. Faruque, A. S. G. Faruque, Yoshifumi Takeda, David A. Sack
G. Balakrish Nair
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gbnair@icddrb.org
Firdausi Qadri
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Holmgren
2Department of Microbiology and Immunology, The Sahlgrenska Academy at Goteborg University & Gothenburg University Vaccine Research Institute, Goteborg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann-Mari Svennerholm
2Department of Microbiology and Immunology, The Sahlgrenska Academy at Goteborg University & Gothenburg University Vaccine Research Institute, Goteborg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashrafus Safa
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nurul A. Bhuiyan
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Q. Shafi Ahmad
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shah M. Faruque
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. S. G. Faruque
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshifumi Takeda
3Cine-Science Laboratory, Itabashi, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Sack
1ICDDR,B: Centre for Health and Population Research, Mohakhali, Dhaka, Bangladesh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01304-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We determined the types of cholera toxin (CT) produced by a collection of 185 Vibrio cholerae O1 strains isolated in Bangladesh over the past 45 years. All of the El Tor strains of V. cholerae O1 isolated since 2001 produced CT of the classical biotype, while those isolated before 2001 produced CT of the El Tor biotype.

Vibrio cholerae O1 has two biotypes, namely, classical and El Tor, which are believed to have evolved from separate lineages (7, 8), and these biotypes have traditionally been differentiated by a number of phenotypic traits. Comparative genomic analyses have recently revealed a high degree of conservation among diverse strains of V. cholerae but have also shown genes that differentiate the classical biotype from the El Tor biotype (3). Apart from these phenotypic and genetic differences, there are also dissimilarities in the infection patterns of disease caused by the two biotypes. These include the occurrence of more asymptomatic than symptomatic carriers of El Tor strains, who outnumber active patients by a ratio of up to 50:1 (14), better survival of El Tor strains in the environment and in the human host, and more efficient host-to-host transmission of El Tor strains than of classical strains (5). There is firm evidence that the fifth and sixth pandemics of cholera were caused by the classical biotype, while the ongoing seventh pandemic is caused by the El Tor biotype, which has now globally replaced the classical biotype.

Cholera toxin (CT), the principal toxin produced by V. cholerae O1 and O139, is responsible for most of the manifestations of the disease cholera. Based on the B subunit of CT, two immunologically related but not identical epitypes have been described: CT1 is the prototype elaborated by classical biotype strains and by U.S. Gulf Coast strains, while CT2 is produced by the El Tor biotype and O139 strains (4). Another classification identifies three types of ctxB genes based on three nonrandom base changes resulting in changes in the deduced amino acid sequence. Genotype 1 is found in strains of the classical biotype worldwide and in U.S. Gulf Coast strains, genotype 2 is found in El Tor biotype strains from Australia, and genotype 3 is found in El Tor biotype strains from the seventh pandemic and the Latin American epidemic (12). Thus, the V. cholerae O1 El Tor biotype of the ongoing seventh pandemic produces CT of the CT2 epitype and genotype 3, while the classical biotype CT belongs to the CT1 epitype and genotype 1. In this study, we examined a collection of clinical V. cholerae O1 strains isolated in Bangladesh during the past four and a half decades, using monoclonal antibodies (MAbs) produced to classical and El Tor CTs, and found that V. cholerae O1 El Tor strains isolated since 2001 in Bangladesh produce the CT subtype of the classical biotype.

One hundred eighty-five strains of V. cholerae O1, consisting of 31 strains of the classical biotype isolated between 1960 and 1990 and 113 strains of the El Tor biotype and 41 hybrid strains of V. cholerae O1 (strains that could not be biotyped as El Tor or classical by conventional phenotypic tests) isolated between 1960 and 2005, were included in this study. These strains were selected from different months within a year and from different years from the ICDDR,B culture collection. All strains were isolated from cases of acute watery diarrhea in patients admitted to the cholera hospital in Dhaka, Bangladesh. The identities of the strains were reconfirmed by the slide agglutination test using specific antisera (13). For biotype analysis, we used chicken erythrocyte agglutination, sensitivity to polymyxin B, and Mukerjee classical phage IV and Mukerjee El Tor phage 5 tests (11).

The detection of the CT subtype was performed by ganglioside GM1-specific enzyme-linked immunosorbent assays (ELISAs) (15), using mouse MAbs specific for the CT subtype produced by the El Tor (ETC 31:20; MAb raised against the CT produced by El Tor strain N16961) or the classical (CT 21:15; MAb raised against the CT produced by classical strain 569B) biotype as well as a MAb that reacts with the CT subtypes of both biotypes (LT 39:13:1) (16). V. cholerae O1 was cultured in AKI medium at 37°C overnight (6). Optical densities of 0.4 or more above the background in the ELISA were considered positive. Nucleotide sequencing of the ctxB genes of eight strains of V. cholerae O1 El Tor isolated between 2001 and 2005 that produced the classical subtype of CT and multiple sequence alignment was performed as previously described (10). The nucleotide sequences of the reference strains were compared with the corresponding sequences of El Tor strain N16961 (GenBank accession no. NC-002505) and classical strain 569B (GenBank accession no. U25679), which were retrieved from GenBank by BLAST searches.

The CT subtypes of a total of 185 strains of V. cholerae O1 isolated over a period of 45 years were examined by the CT subtype-specific ELISA. As shown in Table 1, all 31 classical biotype strains produced CT of the classical subtype. All of the El Tor and hybrid strains of V. cholerae O1 isolated between 2001 and 2005 that were included in the study produced CT of the classical subtype. This is in contrast to the El Tor strains isolated from 1971 to 2000, which produced predominantly CT of the El Tor subtype.

View this table:
  • View inline
  • View popup
TABLE 1.

Cholera toxin subtypes produced by different biotypes of Vibrio cholerae O1 isolated from 1960 to 2005, based on an ELISA using monoclonal antibodies specific to the El Tor and classical subtypes of CT

Nucleotide sequence analysis of the ctxB genes of eight representative El Tor strains of V. cholerae O1 isolated from 2001 to 2005 that produced CT of the classical subtype revealed that the strains possess DNA sequences identical to that of the classical type of ctxB. The deduced amino acid sequences of all eight representative El Tor O1 strains were aligned with the CtxB sequences of the reference strains N16961 (El Tor) and 569B (classical). The deduced amino acid sequences of all eight representative strains were found to be identical to the deduced amino acid sequence of the CT of the 569B classical reference strain, with a histidine at position 39 and a threonine at position 68 (Fig. 1), thereby confirming the results of the CT subtype-specific ELISA.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Amino acid sequence alignment of CT B subunits of representative El Tor V. cholerae isolates from Dhaka, Bangladesh, isolated between 2001 and 2005, that produced the classical subtype of CT, plotted relative to the El Tor reference (identical residues are indicated with dots). The amino acid sequences of the B subunits of V. cholerae 569B (classical) and N16961 (El Tor) were obtained from GenBank.

The epitype and genotype of the CT of the El Tor strains currently associated with cholera in Bangladesh have shifted from epitype CT2 and genotype 3 to epitype CT1 and genotype 1. Thus, in effect, the present El Tor biotype strains produce CT of the classical biotype. The production of classical CT by the El Tor biotype per se is not novel and has been reported infrequently (1, 11, 17). In fact, U.S. Gulf Coast clones of V. cholerae O1 are El Tor strains that possess the classical CT (12). What is novel in the present study is that El Tor strains producing classical CT have completely replaced the prototype seventh pandemic El Tor strains producing the El Tor CT in Bangladesh. Given that there are differences between the classical and El Tor biotypes, the selection of this altered type of strain seems to indicate an evolutionary optimization of the El Tor biotype and could represent a new, more efficient emerging form of the El Tor biotype of V. cholerae O1.

These altered El Tor biotype strains cannot be differentiated from other El Tor strains by currently used bacteriological methods, and therefore a revision in methods is needed to track the spread of such strains. The implications of the heterogeneity in the B subunit of the CTs of the altered El Tor strains also need to be assessed from a vaccine and diagnostic perspective. It has been shown that various polyclonal antisera raised against CT1 antigens neutralize CT2 considerably less effectively than they neutralize the homologous toxin (9). Vaccines partly based on the B subunit from classical strains have been shown to protect less efficiently against El Tor strains than against classical strains in field trials (2). How the altered El Tor biotype strains will influence the epidemiology of cholera remains to be seen.

Nucleotide sequence accession numbers.

The nucleotide sequences obtained for the ctxB genes of strains MQ1687, AU29037, CIRS098, CIRS101, CIRS164, VC071, VC073, and R001 have been deposited in GenBank under accession numbers DQ523204 and DQ523217 to DQ523223.

ACKNOWLEDGMENTS

This research study was funded by the ICDDR,B: Centre for Health and Population Research and its donors, who provide unrestricted support to the center for its operations and research. Current donors providing unrestricted support include the Australian International Development Agency (AusAID), the Government of Bangladesh, the Canadian International Development Agency (CIDA), The Kingdom of Saudi Arabia (KSA), the Government of The Netherlands, the Government of Sri Lanka, the Swedish International Development Cooperative Agency (Sida-SAREC), the Swiss Development Cooperation (SDC), and the Department for International Development, (DFID), United Kingdom. We gratefully acknowledge these donors for their support and commitment to the center's research efforts.

FOOTNOTES

    • Received 26 June 2006.
    • Returned for modification 1 August 2006.
    • Accepted 14 August 2006.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    Ansaruzzaman, M., N. A. Bhuiyan, G. B. Nair, D. A. Sack, M. Lucas, J. L. Deen, J. Ampuero, C. L. Chaignat, and the Mozambique Cholera Vaccine Demonstration Project Coordination Group. 2004. Cholera in Mozambique, variant of Vibrio cholerae. Emerg. Infect. Dis.10:2057-2059.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Clemens, J. D., D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, M. R. Rao, M. R. Khan, M. Yunus, N. Huda, B. F. Stanton, B. A. Kay, R. Eeckels, J. D. Clemens, M. R. Rao, B. A. Kay, D. A. Sack, J. R. Harris, B. F. Stanton, S. Walter, R. Eeckels, A.-M. Svennerholm, and J. Holmgren. 1990. Field trial of oral cholera vaccines in Bangladesh: results from a three-year follow-up. Lancet335:270-273.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Dziejman, M., E. Balon, D. Boyd, C. M. Fraser, J. F. Heidelberg, and J. J. Mekalanos. 2002. Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc. Natl. Acad. Sci. USA99:1556-1561.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Finkelstein, R. A., F. Burks, A. Zupan, W. S. Dallas, C. O. Jacob, and D. S. Ludwig. 1987. Epitopes of the cholera family of enterotoxins. Rev. Infect. Dis.9:544-561.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Finkelstein, R. A. 25 February 2006, posting date. Cholera, Vibrio cholerae O1 and O139, and other pathogenic vibrios. [Online.] http://gsbs.utmb.edu/microbook/ch024.htm .
  6. 6.↵
    Iwanaga, M., K. Yamamoto, N. Higa, Y. Ichinose, N. Nakasone, and M. Tanabe. 1986. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol. Immunol.30:1075-1083.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Kaper, J. B., H. B. Bradford, N. C. Roberts, and S. Falkow. 1982. Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J. Clin. Microbiol.16:129-134.
    OpenUrl
  8. 8.↵
    Karaolis, D. K., R. Lan, and P. R. Reeves. 1995. The sixth and seventh cholera pandemics are due to independent clones separately derived from environmental, nontoxigenic, non-O1 Vibrio cholerae. J. Bacteriol.177:3191-3198.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Marchlewicz, B. A., and R. A. Finkelstein. 1983. Immunological differences among the cholera/coli family of enterotoxins. Diagn. Microbiol. Infect. Dis.1:129-138.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Mitra, R. K., R. K. Nandy, T. Ramamurthy, S. K. Bhattacharya, S. Yamasaki, T. Shimada, S. Toshio, Y. Takeda, and G. B. Nair. 2001. Molecular characterisation of rough variants of Vibrio cholerae isolated from hospitalised patients with diarrhoea. J. Med. Microbiol.50:268-276.
    OpenUrlPubMedWeb of Science
  11. 11.↵
    Nair, G. B., S. M. Faruque, N. A. Bhuiyan, M. Kamruzzaman, A. K. Siddique, and D. A. Sack. 2002. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J. Clin. Microbiol.40:3296-3299.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Olsvik, O., J. Wahlberg, B. Petterson, M. Uhlen, T. Popovic, I. K. Wachsmuth, and P. I. Fields. 1993. Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J. Clin. Microbiol.31:22-25.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Qadri, F., R. Raqib, F. Ahmed, T. Rahman, C. Wenneras, S. K. Das, N. H. Alam, M. M. Mathan, and A.-M. Svennerholm. 2002. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol.9:221-229.
    OpenUrlCrossRefPubMed
  14. 14.↵
    Sack, D. A., R. B. Sack, G. B. Nair, and A. K. Siddique. 2005. Cholera. Lancet63:223-233.
    OpenUrlCrossRef
  15. 15.↵
    Svennerholm, A.-M., and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Curr. Microbiol.1:19-23.
    OpenUrlPubMed
  16. 16.↵
    Svennerholm, A.-M., M. Wikstrom, M. Lindblad, and J. Holmgren. 1986. Monoclonal antibodies to Escherichia coli heat-labile enterotoxins: neutralising activity and differentiation of human and porcine LTs and cholera toxin. Med. Biol.64:23-30.
    OpenUrlPubMed
  17. 17.↵
    Tamplin, M. L., R. Jalali, M. K. Ahmed, and R. R. Colwell. 1990. Variation in epitopes of the B subunit of Vibrio cholerae non-O1 and Vibrio mimicus cholera toxins. Can. J. Microbiol.36:409-413.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh
G. Balakrish Nair, Firdausi Qadri, Jan Holmgren, Ann-Mari Svennerholm, Ashrafus Safa, Nurul A. Bhuiyan, Q. Shafi Ahmad, Shah M. Faruque, A. S. G. Faruque, Yoshifumi Takeda, David A. Sack
Journal of Clinical Microbiology Nov 2006, 44 (11) 4211-4213; DOI: 10.1128/JCM.01304-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh
G. Balakrish Nair, Firdausi Qadri, Jan Holmgren, Ann-Mari Svennerholm, Ashrafus Safa, Nurul A. Bhuiyan, Q. Shafi Ahmad, Shah M. Faruque, A. S. G. Faruque, Yoshifumi Takeda, David A. Sack
Journal of Clinical Microbiology Nov 2006, 44 (11) 4211-4213; DOI: 10.1128/JCM.01304-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Nucleotide sequence accession numbers.
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cholera
Cholera Toxin
Vibrio cholerae O1

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X